foxo4-dri news FOX04-DRI (10mg) – Nordsci The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Particle FOXO4 DRI (Proxofim) is a synthetic peptide with a retro inverted structure, developed as a modified version of the natural FOXO4 protein. Scientific interest in this compound is growing, especially within FOXO4 DRI Beverly Hills Rejuvenation Center Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry
Pay in 4 interest-free payments of $7.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22


